Beta Amyloid (1-42) Monoclonal Antibody, PerCP Conjugated
Product Specifications
Background
The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Gene ID
351
Host
Mouse
Cross Reactivity
Rat
Target
Beta Amyloid 1-42
Clonality
Monoclonal
Isotype
IgG
Clone
1F4
Conjugation
PerCP
Source
KLH conjugated synthetic peptide derived from human beta-Amyloid (1-42)
Applications
WB, IF (IHC-P)
Purification
Purified by Protein G.
Excitation Emission
482nm/677nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-0107M-PerCP
Gene ID URL
351
Predicted Cross Reactivity
Human, Mouse
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items